JVM Co

JVM Co EBIT Margin

The EBIT Margin (Operating Margin) of JVM Co (054950.KQ) as of Nov 4, 2026 is 19.22 %. In the previous year, EBIT Margin (Operating Margin) was 19.24 % — a change of -0.10% (lower).

EBIT Margin

19.22 %

YoY

-0.10%

Last updated:

EBIT Margin (Operating Margin) of JVM Co is 2025 19.22 % . EBIT Margin (Operating Margin) of JVM Co was 2024 19.24 % . It decreases by -0.10% lower compared to the previous year.

JVM Co's operating (EBIT) margin stands at 19.2%, up from 9.6% several years earlier.

The JVM Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
8.96 KRW
Jan 1, 2019
5.39 KRW
Jan 1, 2020
11.18 KRW
Jan 1, 2021
9.65 KRW
Jan 1, 2022
14.07 KRW
Jan 1, 2023
18.95 KRW
Jan 1, 2024
19.24 KRW
Jan 1, 2025
19.22 KRW
The JVM Co EBIT Margin history
YEAREBIT MarginYoY
19.22 %-0.10%
19.24 %+1.52%
18.95 %+34.70%
14.07 %+45.83%
9.65 %-13.74%
11.18 %+107.39%
5.39 %-39.80%
8.96 %-19.14%
11.08 %-7.61%
11.99 %+124.38%
5.34 %-60.87%
13.66 %+6,120.30%
0.22 %+16.92%
0.19 %-29.77%
0.27 %+50.47%
0.18 %-30.48%
0.26 %-32.87%
0.38 %+21.88%
0.31 %+4.08%
0.30 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

EBIT Margin (Operating Margin) of JVM Co is 19.22 % in 2025.

EBIT Margin (Operating Margin) of JVM Co changed from 19.24 % to 19.22 %, representing a -0.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) JVM Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s JVM Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — JVM Co

All Key Metrics — JVM Co